At present, the largest group of radiopaque contrast agents (RCA) is represented by iodinecontaining RCA. However, the development of abdominal interventional X-ray surgery places stringent requirements upon RCA. High contrast must be combined with pharmacological and physiological inertness, low toxicity, with the ability to be uniformly adsorbed as a thin layer on the surface of mucous organs and cavity walls without accumulating in minor-diameter lumens to avoid their obstruction, as well as with the ability to be quickly excreted from the organism. With oil or water-soluble iodine-and barium-containing RCA it is not possible for several reasons to completely estimate for example the hepatic tree lumens or the ducts of other organs since these preparations not always provide uniform and fine contrasting. Water-soluble iodine-containing RCA intended for parenteral introduction enjoyed wide application (urographin, trazograph, omnipaque, etc.). The preparations of this group are also used for direct contrast studies of hollow organs. However, they are found to be absorbed into blood in the small intestine during contrast studies of gastrointestinal tract organs and hepatobiliary system. They have a toxic effect on blood, kidneys, liver, and especially on the thyroid gland. The aim of this study was to develop new gel RCA, in which the substances are tantalates of rare-earth elements or solid solutions based thereon. Lanthanum orthotantalate LaTaO 4 and solid solutions La 1 X Gd X TaO 4 were considered as such substances. The RCA were examined in vitro and in vivo. When gel lanthanum orthotantalate was used as a RCA for contrast studies of the bile passages, this method exhibited a high resolving power in the examination of the hepatic tree and the gallbladder and in the diagnostics of intracavitory masses in ducts and the gallbladder. In contrast to iodine-containing urografin, this RCA has no negative effect on the mucous tunic of the bile passages of laboratory animals. Using the substitutional solid solutions, one can continuously change the specific effectiveness of RCA by gradual varying of the composition and the average size of the substance particles.
INTRODUCTION
In X-ray diagnostics with RCA, the challenge is to develop universal safe radiopaque contrast agents suitable for X-radiation with energies from 20 to 100 keV. Such radiation is emitted by modern medical X-ray units.
Currently, iodine-containing RCA have been extensively used for contrast studies. However, these agents have a number of drawbacks. They produce a toxic effect on blood, liver, kidneys, pancreas, the central nervous system, and the endocrine system (especially on the thyroid gland). They have a local irritant action on mucous tunics, including epithelium of tracheobronhial tree, hepatic and pancreatic ducts, endothelium of arterial, venous, and lymphatic vessels and heart, as well as arachnoid membranes. Besides, they exert various allergic reactions, anaphylactic shock included. Therefore, the search for new effective RCA without such drawback is being well under way.
In this paper we describe new RCA in the form of liquid gels, which are suspensions based on RE tantalates and their solid solutions [1] [2] [3] [4] .
Tantalates of the composition MTaO 4 (M = Y, La, Ln) have different K-absorption jumps ( Table 1) . Therefore, using the substances that contain these chemical elements, it is possible to vary the radiation absorption and to change smoothly the image contrast.
These RCA can be used for contrast studies of hollow organs and for X-ray surgery of gastrointestinal tract and bile passage organs.
RESULTS AND DISCUSSION
In work [5] we reported about new gel RCA based on YTaO 4 and LaTaO 4 . These compounds are white colorless odor-free powders, which are insoluble in water and ethyl alcohol. They have a high chemical stability to acids (HCl, HNO 3 , H 2 SO 4 , H 3 PO 4 , HClO 4 ). The density of YTaO 4 is 7.60 and that of LaTaO 4 is 7.63 g/cm 3 . The melting temperature is respectively 2060 and 1930 C [6] .
Tantalates MTaO4 (M = Y, Gd) are close to structure fergusonite (space group I2/a, Z = 4) [6] . For this structure two forms M and M' are characteristic. Coordination (MO 8 ) is typical for both M-and M forms' as a cube with insignificant dodekaedrichesky distortion, and in the form of M' additional atoms of oxygen are more approached to atoms of tantalum, than in the form of M. Atoms of tantalum remain in slightly distorted tetrahedrons of TaO 4 .
The crystal structure of LaTaO 4 has at a low temperature a monoklinny singoniya (space group P2 1 /c, Z = 4). Ions of tantalum have coordination number (CN) 6 and are located in the distorted octahedrons connected by tops and forming layers. These layers are connected by the ions of lanthanum with CN = 8. Figure 1 shows the X-ray diffraction pattern of the synthesized MTaO4 (M = to La, Gd). The lattice parameters of LaTaO4: a = 7.6397 b = 5.5808, c = 7.8363Å. The lattice parameters of GdTaO4: a = 5.374 b = 11.096, c = 5.106Å. Figure 2 shows the crystal structures of tantalates. Figure 3 presents the dependence between the mass attenuation factor of X-radiation with lanthanum orthotantalate (placeLOT) LaTaO 4 and the energy of X-ray quanta [7] . K-absorption jumps for La and Ta are depicted. It was shown experimentally that the peak on the diagnostic spectrum of X-radiation is at 72 ± 6 keV [8] . So, it can be concluded that the image contrast will be higher with Ta-containing preparations than with those containing iodine (the K-jump of tantalum is at 67.403, while that of iodine is at 33 keV). In the chemical composition of RE tantalates there are two chemical elements: tantalum and lanthanides having the K-absorption jumps in the range from 17.038 to 63.31 keV ( Table 1) . That is why these compounds provide radiation absorption practically over the whole range of applied quantum energies. This was experimentally confirmed for LaTaO 4 .
Lanthanum orthotantalate
Experimental dependences between attenuation of X-radiation (µ/r) for films, on which different RCA powders were applied, and the voltage (U) across the tube with a tungsten anode are shown as an example in Figure 4 . A 22 mm thick phantom filter was used. Here, µ = (I0 -I)/I0, I0 is the intensity of radiation falling on the film and I is the intensity of radiation passing through the film. The surface density (r) of LaTaO 4 , BaSO 4, and Ta films is 1.44, 2.36, and 3.04 mol/cm 2 , respectively. From this Figure it is seen that the attenuation of radiation µ/r sur for LaTaO 4 is greater than for other known agents. Acute and chronic toxicity and safety, biocompatibility of placeLOT during intragastric and intraperitoneal introduction and during application on cutaneous covering and mucous tunics, sewn under the skin and muscles of laboratory animals have been examined. In these studies we estimated the local irritant and dermatoresorbtive action of the preparation, its effect on the functional state of cardiovascular and external respiration systems, the gastrointestinal tract, and the central nervous system. All these studies showed that the use of placeLOT is biocompatibility and safe.
The radiopaque properties of placeLOT were compared in vivo with those of barium sulfate and urografin. placeLOT was used as gel suspensions with concentrations 5, 10, 15, 20, 25, and 30 %. The gel was a natural polysaccharide. The RCA was introduced into the stomach of laboratory rats. X-ray filming was carried out immediately after the introduction and in 3, 6, 12, 24, and 48 h. The results were estimated visually: at 20, 25, and 30 % concentrations of placeLOT, sharp contours of esophagus, stomach, and small intestine were obtained on X-ray films. The intensity, contrast, and definition of X-ray images of organs contrasted with a 30 % gel suspension of placeLOT corresponded or were superior to those obtained with the use of 30 % urografin or the standard barium suspension, respectively ( Figure 5 ). Complete excretion of placeLOT from the gastrointestinal tract was registered in 24 to 48 h depending on the concentration. During intraperitoneal introduction, on the 7th day the whole of the RCA was localized in the lower part of the abdominal cavity and in the small pelvis. When in muscles are sewn the encapsulation occurred without inflammation. These facts show that this preparation is not absorbed into blood during parenteral introduction (except intravascular introduction).
In order to examine the ability of placeLOT in contrasting bile passages and to estimate the state of the hepatic tree cavities, we performed the studies on dogs. 5 to 8 ml of 20 and 30 % gel placeLOT were introduced into the gallbladder cavity. Right after the introduction we performed X-ray studies. The obtained X-ray films contained clear-cut images of the gallbladder cavity, the cystic duct, intra-and extrahepatic bile passages, and partly of the duodenum lumen ( Figure 6 ). Complete evacuation of 20 and [7] 30 % placeLOT from the hepatic tree occurred in 3 and 6 h, respectively.
In the experiments on dogs we simulated the presence of concrements in the gallbladder. For this purpose we introduced three bilestones 5, 7, and 10 mm in diameter into the gallbladder cavity. A drainage tube was run through the stomach opening into the gallbladder lumen, through which placeLOT with concentrations 10, 20, and 30 % were introduced. After introduction of the RCA we carried out X-ray studies under the same physical and technical conditions. At the 10 % concentration of placeLOT, the X-ray films clearly exhibited all the three concrements, but the image contrast and intensity of the hepatic ducts were slightly reduced. At the 20 % concentration, 7 and 10 mm concrements and the hepatic ducts were clearly visible on the X-ray films. When the concentration of placeLOT was 30 %, the concrements were not distinctly visualized, but the intra-and extrahepatic bile passages were clearly seen ( Figure 7) .
The following features were noted during the histological studies of the laboratory dog's gallbladder after the introduction of the 30 % suspension of placeLOT. The columnar epithelium was retained along the whole length of the gallbladder. Plethoric capillaries and venules and moderate lymphocytic infiltration were observed in the autogenous plasty of the connective tissue. The muscular and serous coats were represented by a smooth muscular tissue without pathological changes (Figure 8) . After the introduction of urografin, the epithelial lining was absent over a large area of the gallbladder from the autogenous plasty of the mucous tunic to the distal part of the muscular coat of hemorrhage; in some instances, large-focal necrosis and leucocytic infiltration were noted. Spasm and edema were observed in the muscular coat ( Figure 9) .
Thus, when placeLOT in the gel form was used as a RCA for X-ray studies of the bile passages, this method exhibited a high resolving power in the examination of the hepatic tree and the gallbladder and in the diagnostics of intracavitory masses in ducts and the gallbladder. Unlike iodine-containing urografin, the gel suspension of placeLOT exerts no negative effect on the mucous tunic of bile passages of laboratory animals.
Solid solutions
The new RCA-substitutional solid solutions of the composition La 1 X Gd X TaO 4 (x = 0 -0.18) -have been synthesized. Figure 10 shows the X-ray diffraction pattern of the synthesized solid solutions La 1 X Gd X TaO 4 . In Table 2 unit cell parameters for La 1 x Gd x TaO 4 solid solutions are given. Figure 11 shows microelectronic images of the synthesized phases LaTaO 4 and La 0,98 Gd 0,12 TaO 4 as an example. The presence of the phases of interest in the obtained samples was corroborated during the signal recording in the reflected electron mode. Figure 12 demonstrates the dependence of the mass attenuation factor of X-radiation with these compounds [7] . Characteristic dependences between the average opacity <S> of images on the X-ray film of vials with the gel suspensions of the examined substances and the composition x and the average particle size <r> are presented in Figure 13 . The vials were irradiated with X-ray quanta under various physical and technical conditions; the <r>(x) dependence is also given.
The least S value was observed for the solid solution La 0.82 Gd 0.18 TaO 4 . The physical and technical conditions also affect the S value. If the voltage on the X-ray tube increases from 40 to 52 kV, the opacity value of the X-ray film for this substance lowers. Therefore, this substance provides the highest X-ray contrast in the series of solid solutions. From the diagrams in Figure 13 it is well seen that by changing the quantitative composition of RCA containing the same chemical elements it is possible to change the radiation attenuation and, consequently, to alter the contrast of the substances, which is very important for designing of new RCA. Thus, the specific efficiency of the substances can be continuously changed by varying smoothly their composition and the average particle size. From these diagrams it can be also concluded that the X-ray contrast of the substances can be controlled not only by variation of their composition, but also by alteration of the physical and chemical conditions of filming. 
CONCLUSIONS
In the studies performed it was established that the gel suspension of placeLOT is not toxic with respect to animal organism and does not lead to side effects typical of iodine-containing RCA. It has a pronounced ability to absorb X-rays and provides adequate X-ray images during contrast studies of hollow organs of test animals. It is quickly excreted from the gastrointestinal tract causing no discomfort for test animals. As distinct from iodine-containing urografin, it has neither local irritant action on the mucous tunic of the gallbladder nor the spastic effect on the smooth muscels of the bile passages.
The optimal concentrations of placeLOT for roentgenoscopy of the stomach of rats are 25 and 30 %. When placeLOT is used for contrast studies of the bile passages of dogs, this method exhibits a high resolving power in the determination of the hepatic tree and the gallbladder and in the diagnostics of intracavitory masses in ducts and the gallbladder. It was established that the optimal concentration of the gel suspension of placeLOT is 10 % for cholecystography, 20 % for cholecystocholangiography, and 30 % for cholangiography.
The gel suspensions based on the solid solutions La 1 X Gd X TaO 4 (x = 0 -0.18) allow of continuous and smooth alteration of X-ray contrast of RCA thus expanding the fields of their application.
MATERIALS AND METHODS
The substances were synthesized from the corresponding oxides in the solid phase. As raw materials used reagent Ta To synthesize La 1 X Gd X TaO 4 (x = 0 -0.18) samples used LaTaO 4 and GdTaO 4 compounds taken in the relations corresponding the stekhiometricheskikh. X-ray diffraction analysis was performed using a DRON-2.0 diffractometer (CuKa radiation) and ICDD database [9] .
The contrast properties of the synthesized substances were estimated in vitro in comparison with urografin and the standard barium suspension. The gel suspension was prepared with concentrations from 0.25 to 30 %. The compared RCA were placed into 10 ml glass vials. X-ray studies were performed on an Arman-1 device under the following physical and technical conditions for LaTaO 4 : 63 kV, 6 mAs, focal distance 50 cm, cassette size 18⇥24 cm. A RUM-20M X-ray unit was also used. The exposed X-ray film was treated using the usual technology. Comparative evaluation of the radiopaque properties of the gel suspension of placeLOT was carried out also during computed tomography. Axial tomography with 5 mm step was performed on a Syntec-2000 I unit (General Electric, USA) for the tubular vessels with section thickness 5 mm containing RCA samples: 76 and 30 % urografin, 10, 20, and 30 % gel suspensions of LOT, and the standard aqueous suspension of BaSO 4 .
In vivo experiments during contrast studies of the gastrointestinal tract were performed on six groups of rats of both sexes of a Wistar line population (10 animals in each group). The animals were kept in a warm (19-21 C), dry room at certain humidity in cages in groups of 5 to 10 animals; natural illuminance changing, balanced feeding, generous drinking. Painful manipulations and killing were performed under ether anesthesia. Using a metallic gastrointestinal tube, we introduced in a stomach 5 ml of 25% gel suspension of placeLOT for 2 groups, 5 ml of the standard barium suspension for other 2 groups, and 5 ml of 30 % urografin for the rest 2 groups of animals. X-ray studies were carried out right after the introduction and in 1, 3, 6, 12, and 24 h. The results were evaluated visually. To examine the reaction of other tissues to placeLOT, for two groups of albino rats of both sexes (10 animals in each group) we introduced subdermally 1 ml of the preparation with the concentration 25 % into the region of the right huckle. For other analogous groups, 3 ml of the gel suspension of placeLOT of the same concentration were introduced intraperitoneally. X-ray studies were carried out in 1, 3, and 7 days.
The specific properties of the preparation in contrast studies of the hepatic tree of dogs were examined intraoperatively. Experiments were carried out on 22 dogs (11 groups, each consisting of 2 animals of both sexes). For 3 groups we introduced 5 to 8 ml of 10, 20, and 30 % placeLOT suspension into the gallbladder cavity through an injection needle or a rubber drain. For other three groups, the same concentrations were introduced after the introduction of increments into the gallbladder cavity. The histologic specimens were fixed with a 10 % solution of formaldehyde; the sections were colored with hematoxylin and eosin.
The suspensions obtained on the basis of the solid solutions were examined in vitro under different physical and technical conditions with the use of an Arman-1 device. The concentration of the suspensions was 10 %. The opacity of X-ray films was measured on an MD100 microdensitometer.
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